Breakpoints and drug exposure are inevitably closely linked.

Alffenaar, J W C; Akkerman, O W; Bolhuis, M S; Boeree, M J; de Lange, W C M; van der Werf, T S

Alffenaar, J W C; Akkerman, O W; Bolhuis, M S; Boeree, M J; de Lange, W C M; van der Werf, T S.

Afiliación

Alffenaar JW; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands j.w.c.alffenaar@umcg.nl.
Akkerman OW; University of Groningen, University Medical Center Groningen, Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands Tuberculosis Center Beatrixoord, Haren, The Netherlands.
Bolhuis MS; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
Boeree MJ; Radboud University Medical Center and University Lung Centre Dekkerswald, Nijmegen, The Netherlands.
de Lange WC; University of Groningen, University Medical Center Groningen, Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands Tuberculosis Center Beatrixoord, Haren, The Netherlands.
van der Werf TS; University of Groningen, University Medical Center Groningen, Department of Internal Medicine, Groningen, The Netherlands.

Antimicrob Agents Chemother ; 59(2): 1384, 2015 Feb.

Article en En | MEDLINE | ID: mdl-25628393

Asunto(s)

Antituberculosos/uso terapéutico; Isoniazida/uso terapéutico; Rifampin/uso terapéutico; Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico; Femenino; Humanos; Masculino

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Rifampin / Tuberculosis Resistente a Múltiples Medicamentos / Isoniazida / Antituberculosos Límite: Female / Humans / Male Idioma: En Revista: Antimicrob Agents Chemother Año: 2015 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google